Align the clinical record, functional need, guideline, payer policy, authorization, scheduled service, coding and claim before care is delivered whenever the workflow allows.
GOHEALTHCARE PM&R SPECIALTY GUIDE™
Spasticity & Tone Management
Physiatry-led spasticity and tone management covering assessment, goals, therapy, oral agents, botulinum toxin, focal procedures, intrathecal baclofen pathways, documentation, authorization and outcome measurement.
Developed by Pinky Maniri, Founder & Chief Executive Officer, GoHealthcare Practice Solutions
SPASTICITY MANAGEMENT
Goal-directed interdisciplinary management of focal and generalized spasticity with therapy, medication, injection and device pathways.
OPERATIONAL FOCUS
Medical necessity, evidence, guidelines, payer policy, authorization, documentation, coding, reimbursement, denial prevention, compliance and outcomes.
REFERENCE YEAR
2026 — verify current guideline, payer, coding, coverage and regulatory requirements before use.
GoHealthcare Operational Results
98%Company-reported prior authorization approval rate
50 StatesNational prior authorization and utilization-management support
PM&R FocusPhysiatry, rehabilitation therapy, diagnostics, function, access and revenue-cycle operations
Company-reported performance. Results vary by client, payer, specialty, documentation quality, benefit design and case mix. No authorization or payment outcome is guaranteed.
Page Contents
Use the links below to move directly to the clinical, guideline, payer, documentation, coding, reimbursement, denial-management and operational sections.
Clinical & Coverage Foundation
- Evidence at a Glance
- Executive / Direct Answer
- Scope Within PM&R
- Patient Selection, Indications & Referral Readiness
- Evaluation & Functional Baseline
- Medical Necessity Framework
- Risk, Red Flags & Escalation
- Interdisciplinary Plan of Care
- Care-Setting & Transition Considerations
- Operational Workflow: Referral Through Closure
Payer, Documentation, Coding & Operations
- How to Use Clinical Guidelines Correctly
- Medicare & MAC Coverage Controls
- Commercial, Medicaid & Delegated UM Policies
- Documentation Standard
- Coding, Billing & Revenue Integrity
- Outcomes & Functional Measurement
- Common Denials & Prevention Controls
- How I Would Audit This Service Line
- GoHealthcare Clinical Insights
- GoHealthcare Leadership Perspective
01
FOUNDATION
Evidence at a Glance
| Domain | Operational Standard |
|---|---|
| Clinical scope | Spasticity management should begin with functional goals, not a procedure. Tone can impair hygiene, positioning, gait, transfers, dressing, sleep, comfort, skin protection and caregiver burden; in some patients it can also contribute to useful function. Treatment must therefore be individualized. |
| Documentation priority | For botulinum toxin or other focal treatment, the record should identify treated functional problems, specific muscle pattern, prior response, dose/product details as required, guidance method when used, adverse events, therapy coordination and post-treatment goal reassessment. |
| Authorization priority | Prior authorization commonly requires diagnosis, functional impairment, prior conservative management, treatment goals, product/dose information, previous response and requested interval. Specialty-pharmacy versus buy-and-bill rules may change the workflow. |
| Revenue integrity | Drug, injection, guidance and related services have separate coding, units and payer rules. Product-specific HCPCS, NDC requirements, wastage reporting, NCCI edits and MAC/commercial policy must be verified for the actual drug and date of service. |
| Outcome priority | Measure goal attainment, passive function, active function where relevant, pain, caregiver burden, range, gait/transfer performance and patient-specific objectives. Do not rely on tone score alone. |
02
FOUNDATION
Executive / Direct Answer
Spasticity management should begin with functional goals, not a procedure. Tone can impair hygiene, positioning, gait, transfers, dressing, sleep, comfort, skin protection and caregiver burden; in some patients it can also contribute to useful function. Treatment must therefore be individualized.
GoHealthcare operational objective
03
CLINICAL FOUNDATION
Scope Within PM&R
Spasticity management should begin with functional goals, not a procedure. Tone can impair hygiene, positioning, gait, transfers, dressing, sleep, comfort, skin protection and caregiver burden; in some patients it can also contribute to useful function. Treatment must therefore be individualized.
Core populations and use cases
- post-stroke spasticity
- brain injury
- spinal cord injury
- multiple sclerosis
- cerebral palsy and other upper motor neuron syndromes
- focal limb spasticity
- generalized tone disorders
- contracture-risk and hygiene/positioning problems
04
CLINICAL FOUNDATION
Patient Selection, Indications & Referral Readiness
The referral should identify the clinical question, relevant diagnosis, current functional problem, prior treatment, urgency and information needed to determine whether the requested service is appropriate. Referral acceptance is not the same as medical necessity or payer approval.
- Verify patient identity, payer/product and referral source.
- Confirm the requested service and the clinical question.
- Obtain relevant prior notes, imaging, testing and therapy records.
- Identify urgent safety or red-flag issues.
- Determine whether authorization, certification or provider qualification rules apply.
05
CLINICAL FOUNDATION
Evaluation & Functional Baseline
Document distribution, severity, triggers, passive and active range, pain, fixed contracture versus dynamic tone, gait/transfer impact, hygiene, positioning, caregiver burden, prior treatments, therapy response and patient-centered goals.
Clinical insight
A strong baseline is not a list of symptoms. It is a reproducible description of what the patient cannot do, what objective findings explain the limitation, and what skilled PM&R intervention is expected to change.
06
MEDICAL NECESSITY
Medical Necessity Framework
Medical necessity should be established before authorization language is drafted. The record should support a recognized clinical condition, functional impact, reasonable need for skilled care, appropriateness of the requested service, and a plan to measure response.
| Question | Required evidence |
|---|---|
| What is wrong? | Diagnosis, symptoms, objective examination and relevant diagnostic context. |
| Why does it matter? | Functional limitation, safety risk, participation restriction or clinically meaningful impairment. |
| Why this service? | Patient-specific rationale and relationship to alternatives already tried or considered. |
| Why now? | Current severity, trajectory, failed/insufficient care, change in status or transition need. |
| How will success be judged? | Measurable goal, reassessment point and disposition plan. |
07
SAFETY & DIFFERENTIAL
Risk, Red Flags & Escalation
PM&R workflows should include defined escalation rules for new neurologic deterioration, acute cardiopulmonary symptoms, infection, severe uncontrolled pain, acute bowel/bladder change, rapidly progressive weakness, unsafe swallowing, skin breakdown, autonomic symptoms or other condition-specific risks. The exact escalation pathway depends on the service and care setting.
WATCH-OUTS — safety overrides workflow
Do not allow authorization status, scheduling pressure or a preset pathway to delay appropriate clinical escalation when the patient's condition has changed.
08
CARE PLANNING
Interdisciplinary Plan of Care
The PM&R plan should assign ownership across physician/APP care, PT, OT, SLP, diagnostics, behavioral/cognitive services, equipment/O&P, case management and other services when relevant. Goals should be complementary rather than duplicated or contradictory.
- Define the lead clinical problem and shared functional goals.
- Identify discipline-specific skilled contributions.
- Sequence services that depend on prior testing, equipment or intervention.
- Set reassessment and authorization-extension triggers.
- Document discharge or transition criteria.
09
CARE CONTINUUM
Care-Setting & Transition Considerations
Requirements differ across acute care, inpatient rehabilitation, SNF/post-acute, home health, CORF, hospital outpatient and physician/therapy office settings. Do not carry one setting's documentation or billing assumptions into another. Transitions should reconcile medications, equipment, precautions, current function, pending authorizations and follow-up responsibility.
10
OPERATIONS
Operational Workflow: Referral Through Closure
| Stage | Operational control | Evidence |
|---|---|---|
| Referral | Eligibility, clinical question and completeness review | Referral/records checklist |
| Clinical readiness | Evaluation and medical-necessity confirmation | Signed assessment/plan |
| Financial readiness | Benefits, network, authorization and estimate workflow | Eligibility/PA record |
| Scheduling | Only schedule against confirmed readiness rules | Readiness status |
| Service | Document skilled service and response | Encounter note/report |
| Reassessment | Compare progress to baseline/goals | Objective reassessment |
| Extension | Submit updated evidence before authorization exhaustion | PA extension log |
| Closure | Discharge/transition and claim reconciliation | Outcome and financial closure |
11
GUIDELINES
How to Use Clinical Guidelines Correctly
A clinical practice guideline informs care; it does not automatically create payer coverage. A payer policy or Medicare LCD may impose documentation, frequency, provider or authorization requirements that are narrower or simply different. The PM&R operating model should reconcile both layers.
Guideline governance
For each guideline, record the owner, title, publication/update date, population, major recommendations, applicability limits and the workflow elements it affects. Do the same separately for coverage policies.
12
MEDICARE
Medicare & MAC Coverage Controls
For Medicare services, determine whether national policy, a MAC LCD, associated billing-and-coding article, claims-processing rule, benefit-policy manual instruction or other source controls the service. LCDs are jurisdiction specific and can be revised or retired. Verify the patient's MAC and date of service rather than copying criteria from another jurisdiction.
13
PAYER INTELLIGENCE
Commercial, Medicaid & Delegated UM Policies
Commercial and Medicaid plans may use their own medical policies or delegate utilization management to organizations such as Carelon, eviCore, Cohere, Evolent, TurningPoint or other vendors. Delegation can vary by plan, state, service and date. The workflow should identify the actual decision-maker before submission and retain the policy used.
14
DOCUMENTATION
Documentation Standard
For botulinum toxin or other focal treatment, the record should identify treated functional problems, specific muscle pattern, prior response, dose/product details as required, guidance method when used, adverse events, therapy coordination and post-treatment goal reassessment.
| Documentation layer | Minimum operational expectation |
|---|---|
| Clinical assessment | Diagnosis, objective findings, functional impact and differential/risk. |
| Medical necessity | Why skilled care/service is reasonable for this patient now. |
| Plan | Goals, intervention, frequency/duration or next step as applicable. |
| Service note/report | What was done, who performed it, response/findings and decisions. |
| Reassessment | Comparison with baseline and rationale for continue/modify/discharge. |
| Authorization evidence | Policy-specific criteria mapped to the chart without unsupported copy-forward. |
15
CODING & BILLING
Coding, Billing & Revenue Integrity
Drug, injection, guidance and related services have separate coding, units and payer rules. Product-specific HCPCS, NDC requirements, wastage reporting, NCCI edits and MAC/commercial policy must be verified for the actual drug and date of service.
Revenue integrity principle
Coding should be the final expression of a clinically and operationally coherent encounter—not a rescue step used to compensate for missing documentation, authorization or unclear service delivery.
Spasticity / Botulinum Toxin Coding Intelligence
This coding matrix is an operational crosswalk, not a substitute for the current CPT codebook, HCPCS release, ICD-10-CM code set, Medicare NCCI files, payer policy or MAC article. Code descriptors below are deliberately paraphrased rather than reproduced verbatim.
CPT / HCPCS Level I Code Families
| Code | Operational use | Coding control |
|---|---|---|
| 64642–64647 | Extremity/trunk chemodenervation code families based on region and muscle-count structure. | Select exact code from current CPT based on service actually performed. |
| 64612 / 64616 / 64617 | Other anatomic chemodenervation families used for specific clinical regions when applicable. | Do not generalize across indications. |
| 95873 / 95874 | Electrical stimulation or needle-EMG guidance families that may be reportable with selected chemodenervation services when medically necessary. | CMS article says do not report 95874 with 95873. |
Representative ICD-10-CM Diagnosis Crosswalk
| ICD-10-CM | Clinical context | Crosswalk control |
|---|---|---|
| G81.* | Hemiplegia/hemiparesis families | Use specific laterality/dominance where required. |
| G82.* | Paraplegia/tetraplegia families | Clinical indication and treatment goals must be documented. |
| I69.* | Sequelae of cerebrovascular disease | Use the specific neurologic deficit/sequela supported by the chart. |
| G35.* | Multiple sclerosis families | 2026 ICD-10 updates may affect specificity; verify current code set. |
| G80.* | Cerebral palsy families | Use specific type when documented. |
HCPCS Level II Crosswalk
| HCPCS / Family | Operational use | Control |
|---|---|---|
| J0585 | OnabotulinumtoxinA product code family. | Bill units based on current HCPCS definition and product actually administered. |
| J0586 | AbobotulinumtoxinA product code family. | Product-specific units are not interchangeable. |
| J0587 | RimabotulinumtoxinB product code family. | Verify current payer policy. |
| J0588 | IncobotulinumtoxinA product code family. | Verify product, units, NDC and authorization. |
| J0589 | Additional botulinum toxin product code appearing in certain CMS articles. | Verify current HCPCS and payer adoption before use. |
Modifier Matrix
| Modifier | Use | Control |
|---|---|---|
| JW | Reports discarded amount from applicable single-dose container when Medicare rules require. | Drug wastage documentation must support claim. |
| JZ | Attests zero discarded amount from applicable single-dose container when Medicare rules require. | Apply only when rule applies. |
| RT / LT | May apply to certain payer/site reporting scenarios. | Do not substitute for procedure-specific bilateral rules. |
| 50 | Do not assume bilateral modifier is valid for chemodenervation code families. | CMS article examples note bilateral indicator considerations; verify MPFS/payer. |
CODING CONTROL — VALID CODE ≠ COVERED SERVICE
A syntactically valid CPT, HCPCS or ICD-10-CM code does not establish medical necessity, authorization, benefit eligibility or payment. Reconcile diagnosis, procedure, units, modifiers, site of service, provider, authorization and current payer/MAC policy before billing.
Primary coding sources: CMS 2026 Therapy Code List · CMS NCCI · CMS MUE.
GOHEALTHCARE CODING INTELLIGENCE
Use the dedicated coding libraries for current code-family navigation and crosswalk methodology: PM&R CPT & HCPCS Coding Library, PM&R ICD-10-CM Diagnosis Crosswalk Library, and PM&R Modifiers, NCCI & MUE Reference. The service-specific page remains the controlling operational context.
16
OUTCOMES
Outcomes & Functional Measurement
Measure goal attainment, passive function, active function where relevant, pain, caregiver burden, range, gait/transfer performance and patient-specific objectives. Do not rely on tone score alone.
Use validated instruments when appropriate, but avoid collecting scores without a management plan. Define baseline timing, follow-up timing, eligible population, completion-rate target and how results influence treatment, authorization and discharge.
17
DENIAL PREVENTION
Common Denials & Prevention Controls
| Failure mode | Prevention control |
|---|---|
| No/incorrect authorization | Payer/product/UM-vendor verification and authorization ledger. |
| Medical necessity not supported | Criteria-to-record review before submission. |
| Documentation inconsistency | Clinical-to-PA-to-claim reconciliation. |
| Units/frequency outside policy | Real-time utilization tracking and pre-service edit. |
| Provider/site mismatch | Credentialing, network and location validation. |
| Outdated policy used | Version-controlled policy library and effective-date check. |
WATCH-OUTS — the denial is usually downstream
Root-cause the earliest control failure rather than treating the denial code as the whole problem.
18
AUDIT & COMPLIANCE
How I Would Audit This Service Line
Select a risk-based sample and trace each case from referral through clinical assessment, policy selection, authorization, service, documentation, coding, claim and payment. Reconcile what was requested, approved, performed, documented and billed. Classify defects by root cause and re-test after corrective action.
- Clinical appropriateness and guideline concordance
- Authorization completeness and validity
- Documentation sufficiency
- Coding/units/modifiers
- Provider/site requirements
- Outcome measurement
- Payment/denial reconciliation
19
GOHEALTHCARE INSIGHT
GoHealthcare Clinical Insights
GOHEALTHCARE CLINICAL INSIGHT
The strongest PM&R record explains function. Diagnosis alone rarely tells the complete story; the chart should show how the condition changes mobility, self-care, communication, cognition, participation, safety or work—and why the proposed skilled service is expected to improve or manage that problem.
20
LEADERSHIP
GoHealthcare Leadership Perspective
GOHEALTHCARE LEADERSHIP PERSPECTIVE
Do not manage PM&R as isolated departments. The leadership unit is the patient episode across access, physician care, therapy, diagnostics, equipment, authorization, documentation and revenue integrity. Build dashboards around that episode.
21
PRIOR AUTHORIZATION
GoHealthcare Prior Authorization Insight
GOHEALTHCARE PRIOR AUTHORIZATION INSIGHT
Prior authorization commonly requires diagnosis, functional impairment, prior conservative management, treatment goals, product/dose information, previous response and requested interval. Specialty-pharmacy versus buy-and-bill rules may change the workflow.
22
CASE STUDY
Operational Case Scenario
A post-stroke patient is repeatedly injected because “spasticity returned,” but the chart lacks a functional goal and therapy integration. The corrected pathway defines a hygiene and upper-extremity positioning goal, documents dynamic tone versus contracture, coordinates OT, records treatment response and uses the result to determine whether repeat treatment is justified.
23
BEST PRACTICES
GoHealthcare Best Practices
- Verify the patient, payer, product and controlling policy before service.
- Use a complete clinical and functional baseline.
- Separate clinical guideline from coverage policy.
- Create a live authorization/utilization ledger for services with limits.
- Reconcile approved service with scheduled and performed service.
- Measure outcomes and use them in reauthorization and discharge.
- Audit complete episodes rather than claims alone.
BEST PRACTICES — build controls upstream
The least expensive denial is the one prevented before the patient reaches the schedule.
24
COMMON MISTAKES
Common Mistakes
- Treating authorization as proof of medical necessity.
- Copying old goals or criteria into a new episode.
- Using generic function language instead of measurable limitations.
- Failing to distinguish benefit limits from medical-necessity denials.
- Using a retired or wrong-jurisdiction Medicare policy.
- Scheduling beyond approved dates/units.
- Allowing the claim to be the first point where inconsistencies are discovered.
25
PEARLS & PITFALLS
Pearls and Pitfalls
| Pearl | Pitfall |
|---|---|
| Keep one source of truth for authorization. | Separate spreadsheets that disagree with the schedule. |
| Translate policy criteria into a checklist but retain the source. | Treating the checklist as the legal/coverage authority. |
| Document functional change over time. | Repeating the same subjective narrative every visit. |
| Close the episode clinically and financially. | Stopping at the last visit without outcome/discharge reconciliation. |
26
FAQ
Frequently Asked Questions
Does a clinical guideline guarantee payer coverage?
No. Clinical guidance and coverage policy are different authority layers.
Does prior authorization guarantee payment?
No. Payment still depends on eligibility, benefit, medical necessity, coding, documentation, provider/site requirements and claim rules.
Should every PM&R service use the same outcome measure?
No. Select measures appropriate to the diagnosis, impairment and functional goal, with consistent baseline and follow-up methodology.
How often should payer and guideline sources be reviewed?
Use scheduled surveillance plus event-driven review whenever a payer, CMS, MAC, professional society or regulator releases a material change.
27
EXECUTIVE SUMMARY
Key Takeaways
- PM&R is a function-centered specialty and the operational record should reflect that.
- Clinical guidelines, Medicare coverage and payer authorization criteria must be distinguished and reconciled.
- PT, OT, SLP, EMG/NCS, DME/O&P and physician services require service-specific controls.
- Authorization should be managed prospectively with live utilization tracking.
- Documentation, coding and payment integrity are one connected system.
- Guideline and policy version control is a compliance function, not just a content function.
28
2027 & BEYOND
Future Outlook
Coverage scrutiny will increasingly focus on goal documentation, objective reassessment, product-specific policy and the relationship between intervention and functional outcomes.
CMS interoperability and prior-authorization modernization also increases the importance of structured clinical data, policy versioning and machine-readable evidence. Automation can accelerate the workflow, but governance must ensure that automated rules remain tied to current authoritative sources.
29
GOHEALTHCARE RESOURCES
Related GoHealthcare Resources
30
REFERENCES
Guidelines, Standards & Authoritative References
Applicable Guidelines, Coverage Policies and Professional Standards
GoHealthcare separates clinical guidance from coverage policy. A clinical practice guideline helps inform care; an LCD, NCD, billing article, payer medical policy or utilization-management rule determines coverage and administrative requirements for a specific payer, jurisdiction, benefit and date of service. Verify both layers before relying on this page operationally.
| Source | Guideline / Policy Resource | How to Use It Operationally |
|---|---|---|
| AAPM&R | Consensus Guidance on Spasticity Assessment and Management | PM&R-specific framework emphasizing early identification, reassessment and goal-centered interdisciplinary management. |
| CMS | Botulinum Toxin LCD Example | MAC-specific coverage example; verify current jurisdiction and article. |
| AAPM&R | Spasticity Policy & Advocacy | Current PM&R policy context and coverage issues. |
| APTA | CPG Library | Therapy evidence and condition-specific rehabilitation guidance. |
GUIDELINE CONTROL — DO NOT TREAT A LINK AS THE POLICY
Confirm the current version, effective date, patient payer/product, Medicare Administrative Contractor when applicable, state rules, site of service, provider qualifications and benefit limitations. Retired or superseded policies should remain in the audit trail but should not drive current authorization or billing decisions.
The source list is intentionally weighted toward primary or official sources. Where a Medicare LCD or billing article is shown, it is an example of a MAC policy and may not control the patient's jurisdiction. Always verify the current Medicare Coverage Database record, effective date and associated article.
Need PM&R operational support?
GoHealthcare Practice Solutions supports prior authorization, utilization management, documentation, coding, revenue cycle, operational design and AI governance across PM&R and MSK specialties.
DEVELOPED BY
Pinky Maniri
Founder & Chief Executive Officer, GoHealthcare Practice Solutions
Healthcare operations, prior authorization, revenue cycle, PM&R/MSK specialty operations and healthcare AI governance.
Standard Disclaimer
This material is for educational and operational reference only and does not constitute medical, legal, coding or reimbursement advice. Clinical decisions remain the responsibility of qualified treating professionals. Coverage, authorization, coding and payment rules vary by payer, plan, jurisdiction, provider, site of service and date. CPT is a registered trademark of the American Medical Association. Always verify current primary sources and payer requirements.
GOHEALTHCARE KNOWLEDGE CENTER
Search GoHealthcare Practice Solutions
Use the GoHealthcare website search and related specialty resources to continue your research.